Efficacy & Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary

See also
Status	Clinical Trial	Phase
Completed	`NCT01134562` - Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism	Phase 1
Completed	`NCT02523209` - Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation	N/A
Completed	`NCT01922843` - A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis	Phase 2
Completed	`NCT01651000` - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency	Phase 3
Completed	`NCT00528788` - How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis	Phase 4
Completed	`NCT01181531` - Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis	Phase 4
Completed	`NCT05382988` - Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy	Phase 3
Completed	`NCT02056730` - The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid	Phase 4
Completed	`NCT01704079` - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency	Phase 3
Completed	`NCT00397475` - Evaluation of Colecalciferol Substitution in Dialysis Patients	N/A
Withdrawn	`NCT03063190` - Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease	Phase 4
Completed	`NCT02102204` - Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis	Phase 3
Recruiting	`NCT02273570` - Optimal Anemia Treatment in End Stage Renal Disease (ERSD)	N/A
Completed	`NCT01788046` - Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis	Phase 3
Terminated	`NCT01277510` - Pediatric Chronic Kidney Disease Safety and Efficacy	Phase 3
Terminated	`NCT01439867` - Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism	Phase 2
Completed	`NCT01134549` - Safety, Tolerability and Pharmacokinetics of KAI-4169 in Healthy Male Volunteers	Phase 1
Completed	`NCT01785875` - Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis	Phase 3
Active, not recruiting	`NCT02464072` - Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis	N/A
Completed	`NCT01290029` - Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease	Phase 1

NCT number	NCT01785849
Study type	Interventional
Source	Amgen
Contact
Status	Completed
Phase	Phase 3
Start date	March 12, 2013
Completion date	June 12, 2014

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms